Allakos Inc. (ALLK)Â
NASDAQ
Market Cap
$76.43M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
530 of 950
Rank in Industry
290 of 543
Largest Insider Buys in Sector
ALLK Stock Price History Chart
ALLK Stock Performance
About Allakos Inc.
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and/or eosinophilic duodenitis; a Phase II/III study for eosinophilic esophagitis; and a Phase II clinical study to atopic dermatitis and chronic spontaneous urticaria. It is also developing lirentelimab (AK002) for the treatment of mast cell gastrointestinal disease, chronic urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis; and AK006 to treat allergic and inflammatory diseases. The company was incorporated in 2012 and is headquartered in Redwood City, California.
Insider Activity of Allakos Inc.
Over the last 12 months, insiders at Allakos Inc. have bought $0 and sold $87,935 worth of Allakos Inc. stock.
On average, over the past 5 years, insiders at Allakos Inc. have bought $0 and sold $142.03M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 222,222 shares for transaction amount of $4M was made by MCKEARN JOHN P () on 2018‑07‑23.
List of Insider Buy and Sell Transactions, Allakos Inc.
| 2024-06-28 | Sale | Chief Financial Officer | 87,064 0.0937% | $1.01 | $87,935 | 0.00% | ||
| 2021-09-28 | Sale | director | 4,000 0.0075% | $108.12 | $432,480 | -94.75% | ||
| 2021-06-14 | Sale | President and COO | 20,000 0.0376% | $91.62 | $1.83M | -15.78% | ||
| 2021-06-07 | Sale | President and COO | 2,487 0.0047% | $92.03 | $228,879 | -14.19% | ||
| 2021-06-04 | Sale | Chief Executive Officer | 23,595 0.044% | $89.64 | $2.11M | -12.39% | ||
| 2021-06-04 | Sale | President and COO | 642 0.0012% | $90.26 | $57,947 | -12.39% | ||
| 2021-06-04 | Sale | Chief Medical Officer | 2,435 0.0045% | $89.60 | $218,176 | -12.39% | ||
| 2021-06-03 | Sale | Chief Executive Officer | 20,001 0.0378% | $92.13 | $1.84M | -13.45% | ||
| 2021-06-02 | Sale | Chief Executive Officer | 20,001 0.0369% | $94.55 | $1.89M | -17.34% | ||
| 2021-05-19 | Sale | Chief Executive Officer | 19,998 0.0374% | $98.93 | $1.98M | -18.90% | ||
| 2021-05-18 | Sale | Chief Executive Officer | 20,001 0.0377% | $102.31 | $2.05M | -20.84% | ||
| 2021-05-17 | Sale | Chief Executive Officer | 20,001 0.0369% | $99.68 | $1.99M | -20.43% | ||
| 2021-05-10 | Sale | President and COO | 20,000 0.0377% | $96.02 | $1.92M | -14.94% | ||
| 2021-04-14 | Sale | President, COO and CFO | 20,000 0.0373% | $107.77 | $2.16M | -23.40% | ||
| 2021-04-13 | Sale | President, COO and CFO | 20,000 0.0368% | $103.08 | $2.06M | -21.06% | ||
| 2021-04-12 | Sale | President, COO and CFO | 20,000 0.0373% | $104.40 | $2.09M | -20.99% | ||
| 2021-04-06 | Sale | Chief Medical Officer | 10,000 0.0189% | $111.68 | $1.12M | -24.45% | ||
| 2021-04-05 | Sale | Chief Medical Officer | 20,000 0.0374% | $113.06 | $2.26M | -26.01% | ||
| 2021-04-01 | Sale | Chief Medical Officer | 20,000 0.0374% | $114.40 | $2.29M | -26.91% | ||
| 2021-03-26 | Sale | 17,308 0.0325% | $115.17 | $1.99M | -26.70% |
Insider Historical Profitability
13.36%
| Radford Harlan Baird | Chief Financial Officer | 204390 0.2288% | $0.86 | 0 | 1 | |
| Alta Partners VIII, L.P. | 10 percent owner | 11519200 12.8931% | $0.86 | 1 | 0 | +13.36% |
| RiverVest Venture Fund III, L.P. | 10 percent owner | 5750506 6.4364% | $0.86 | 1 | 14 | +13.36% |
| Walker Paul Edward | director | 2163260 2.4213% | $0.86 | 0 | 2 | |
| Alexander Robert | Chief Executive Officer | 237795 0.2662% | $0.86 | 0 | 9 | |
| Tomasi Adam | President and COO | 148220 0.1659% | $0.86 | 0 | 10 | |
| RASMUSSEN HENRIK S MD | Chief Medical Officer | 98550 0.1103% | $0.86 | 0 | 7 | |
| JANNEY DANIEL | 56293 0.063% | $0.86 | 1 | 6 | +13.36% | |
| Hudson Peter A | 8000 0.009% | $0.86 | 0 | 4 | ||
| MCKEARN JOHN P | director | 1200 0.0013% | $0.86 | 1 | 15 | +13.36% |
| NOHRA GUY P | 10 percent owner | 0 0% | $0.86 | 0 | 2 | |
| MORE ROBERT J | director | 0 0% | $0.86 | 0 | 4 | |
| James Steven P | director | 0 0% | $0.86 | 0 | 2 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Bvf Inc Il | $20.86M | 18.69 | 16.55M | +93.54% | +$10.08M | 0.15 | |
| Nea Management Company Llc | $7.75M | 6.94 | 6.15M | 0% | +$0 | 0.04 | |
| Deep Track Capital Lp | $6.3M | 5.65 | 5M | +99.14% | +$3.14M | 0.03 | |
| BlackRock | $5.95M | 5.33 | 4.72M | -7.73% | -$498,099.38 | <0.0001 | |
| The Vanguard Group | $4.78M | 4.29 | 3.79M | +16.56% | +$679,249.54 | <0.0001 | |
| Redmile Group | $4.35M | 3.9 | 3.45M | -5.98% | -$276,407.47 | 0.04 | |
| Millennium Management LLC | $4.1M | 3.67 | 3.25M | +238.29% | +$2.89M | <0.01 | |
| Citadel Advisors LLC | $3.84M | 3.44 | 3.05M | -6.11% | -$249,907.10 | <0.01 | |
| Vivo Capital | $3.76M | 3.38 | 2.99M | 0% | +$0 | 0.33 | |
| Logos Global Management Lp | $3.65M | 3.28 | 2.9M | 0% | +$0 | 0.4 | |
| Morgan Stanley | $3.22M | 2.88 | 2.55M | -15.62% | -$595,489.84 | <0.0001 | |
| Opaleye Management Inc | $3.07M | 2.75 | 2.44M | New | +$3.07M | 0.68 | |
| Fidelity Investments | $2.88M | 2.59 | 2.29M | +11.01% | +$285,991.07 | <0.0001 | |
| Geode Capital Management | $2.05M | 1.84 | 1.63M | +2.5% | +$50,037.31 | <0.0001 | |
| State Street | $1.77M | 1.59 | 1.41M | +1.58% | +$27,473.05 | <0.0001 | |
| Acadian Asset Management | $1.68M | 1.5 | 1.33M | +1,753.08% | +$1.59M | 0.01 | |
| PLATINUM INVESTMENT MANAGEMENT LTD | $1.48M | 1.32 | 1.17M | +84.57% | +$676,667.94 | 0.02 | |
| Barclays | $1.46M | 1.31 | 1.16M | +1,169.87% | +$1.35M | <0.01 | |
| Walleye Capital | $1.24M | 1.11 | 984,749 | New | +$1.24M | <0.01 | |
| Deutsche Bank | $1.19M | 1.06 | 940,811 | New | +$1.19M | <0.01 | |
| Ikarian Capital LLC | $1.18M | 1.05 | 932,675 | +293.44% | +$876,480.31 | 0.16 | |
| Renaissance Technologies | $1.08M | 0.97 | 855,718 | +80.26% | +$479,977.69 | <0.01 | |
| Gsa Capital Partners Llp | $929,000.00 | 0.83 | 737,323 | New | +$929,000.00 | 0.08 | |
| Ubs Oconnor Llc | $808,498.00 | 0.73 | 641,665 | New | +$808,498.00 | 0.04 | |
| T. Rowe Price | $805,000.00 | 0.72 | 638,102 | -91.94% | -$9.19M | <0.0001 | |
| Northern Trust | $701,604.00 | 0.63 | 556,828 | -1.51% | -$10,778.05 | <0.0001 | |
| Bank of America | $667,316.00 | 0.6 | 529,616 | +46.81% | +$212,772.37 | <0.0001 | |
| D. E. Shaw & Co. | $633,179.00 | 0.57 | 502,523 | +30.57% | +$148,256.64 | <0.01 | |
| ExodusPoint Capital Management, LP | $506,000.00 | 0.45 | 401,729 | New | +$506,000.00 | 0.01 | |
| Citigroup | $346,349.00 | 0.31 | 274,880 | +941.53% | +$313,095.06 | <0.0001 | |
| Nuveen | $319,243.00 | 0.29 | 253,367 | +20.52% | +$54,353.98 | <0.0001 | |
| Boothbay Fund Management LLC | $319,367.00 | 0.29 | 253,466 | +391.65% | +$254,408.99 | 0.01 | |
| Goldman Sachs | $286,524.00 | 0.26 | 227,400 | -17.29% | -$59,890.32 | <0.0001 | |
| Industry Ventures | $259,122.00 | 0.23 | 205,652 | 0% | +$0 | 0.43 | |
| JPMorgan Chase | $253,502.00 | 0.23 | 201,192 | +321.42% | +$193,347.06 | <0.0001 | |
| BNY Mellon | $235,952.00 | 0.21 | 187,263 | -7.78% | -$19,911.83 | <0.0001 | |
| Pennant Capital Management Llc | $234,486.00 | 0.21 | 186,100 | 0% | +$0 | 0.04 | |
| Charles Schwab | $228,981.00 | 0.21 | 181,731 | 0% | +$0 | <0.0001 | |
| AQR Capital | $227,200.00 | 0.2 | 180,318 | +118.34% | +$123,140.69 | <0.0001 | |
| Samsara Biocapital Llc | $216,832.00 | 0.19 | 172,089 | 0% | +$0 | 0.03 | |
| Bridgeway Capital Management | $182,952.00 | 0.16 | 145,200 | -36.92% | -$107,100.00 | <0.01 | |
| Dimensional Fund Advisors | $161,270.00 | 0.15 | 127,992 | -47.1% | -$143,587.15 | <0.0001 | |
| Woodline Partners LP | $146,853.00 | 0.13 | 116,550 | +62.88% | +$56,692.44 | <0.01 | |
| UBS | $140,371.00 | 0.13 | 111,406 | -28.96% | -$57,226.45 | <0.0001 | |
| RhumbLine Advisers | $130,449.00 | 0.12 | 103,538 | +3.46% | +$4,360.56 | <0.0001 | |
| Blair William Co Il | $108,129.00 | 0.1 | 85,817 | -21.06% | -$28,853.89 | <0.0001 | |
| Amundi | $87,694.00 | 0.09 | 82,730 | 0% | +$0 | <0.0001 | |
| Wilshire Associates | $94,569.00 | 0.09 | 75,055 | 0% | +$0 | 0.05 | |
| Utah Retirement Systems | $81,960.00 | 0.07 | 65,048 | 0% | +$0 | <0.01 | |
| SEI Investments Company | $54,354.00 | 0.05 | 43,138 | New | +$54,354.00 | <0.0001 |
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.